Clinical Trial Update: A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study update for NRM-823 in locally advanced or metastatic refractory solid tumors, currently recruiting. The trial lists head and neck squamous cell ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Esophageal Adenocarcinoma
• Esophageal Squamous Cell Carcinoma
• Gastric Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma
• Head and Neck Squamous Cell Carcinoma
• Ovarian Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• NRM-823

Snippet

Sponsor: Normunity AccelCo, Inc. | Conditions: HNSCC, ESCC | Phase 1 | Status: RECRUITING